You are here: Home » News-CM » Companies » Results
Business Standard

Glaxosmithkline Pharma standalone net profit rises 6.29% in the March 2017 quarter

Capital Market 

Sales rise 10.93% to Rs 763.43 crore

Net profit of rose 6.29% to Rs 112.71 crore in the quarter ended March 2017 as against Rs 106.04 crore during the previous quarter ended March 2016. Sales rose 10.93% to Rs 763.43 crore in the quarter ended March 2017 as against Rs 688.18 crore during the previous quarter ended March 2016.

For the full year,net profit declined 10.08% to Rs 336.78 crore in the year ended March 2017 as against Rs 374.53 crore during the previous year ended March 2016. Sales rose 6.09% to Rs 2920.79 crore in the year ended March 2017 as against Rs 2753.02 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales763.43688.18 11 2920.792753.02 6 OPM %17.9118.81 -14.3817.32 - PBDT151.63153.58 -1 491.70598.58 -18 PBT143.84146.69 -2 465.35573.63 -19 NP112.71106.04 6 336.78374.53 -10

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Glaxosmithkline Pharma standalone net profit rises 6.29% in the March 2017 quarter

Sales rise 10.93% to Rs 763.43 crore

Sales rise 10.93% to Rs 763.43 crore

Net profit of rose 6.29% to Rs 112.71 crore in the quarter ended March 2017 as against Rs 106.04 crore during the previous quarter ended March 2016. Sales rose 10.93% to Rs 763.43 crore in the quarter ended March 2017 as against Rs 688.18 crore during the previous quarter ended March 2016.

For the full year,net profit declined 10.08% to Rs 336.78 crore in the year ended March 2017 as against Rs 374.53 crore during the previous year ended March 2016. Sales rose 6.09% to Rs 2920.79 crore in the year ended March 2017 as against Rs 2753.02 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales763.43688.18 11 2920.792753.02 6 OPM %17.9118.81 -14.3817.32 - PBDT151.63153.58 -1 491.70598.58 -18 PBT143.84146.69 -2 465.35573.63 -19 NP112.71106.04 6 336.78374.53 -10

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Glaxosmithkline Pharma standalone net profit rises 6.29% in the March 2017 quarter

Sales rise 10.93% to Rs 763.43 crore

Net profit of rose 6.29% to Rs 112.71 crore in the quarter ended March 2017 as against Rs 106.04 crore during the previous quarter ended March 2016. Sales rose 10.93% to Rs 763.43 crore in the quarter ended March 2017 as against Rs 688.18 crore during the previous quarter ended March 2016.

For the full year,net profit declined 10.08% to Rs 336.78 crore in the year ended March 2017 as against Rs 374.53 crore during the previous year ended March 2016. Sales rose 6.09% to Rs 2920.79 crore in the year ended March 2017 as against Rs 2753.02 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales763.43688.18 11 2920.792753.02 6 OPM %17.9118.81 -14.3817.32 - PBDT151.63153.58 -1 491.70598.58 -18 PBT143.84146.69 -2 465.35573.63 -19 NP112.71106.04 6 336.78374.53 -10

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22